on February 7, 2005
Published online before print February 7, 2005, doi: 10.1161/01.HYP.0000156497.39375.37
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 21, 2004
From the School of Nephrology (G.B.), Dialysis and Hypertension, University Vita Salute San Raffaele, Milan, Italy; Prassis Research Institute Sigma Tau (P.F.), Settimo Milanese, Milan, Italy; and Studiecoördinatircentrum (J.A.S.), Hypertensie en Cardiovasculaire Revalidatie Eenheid, Departement Moleculair en Cardiovasculair Onderzoek, Katholieke Universiteit Leuven, Belgium. * To whom correspondence should be addressed. E-mail: bianchi.giuseppe{at}hsr.it.
Abstract--Adducin is a heterodymeric cytoskeleton protein, the 3 subunits of which are encoded by genes (ADD1, ADD2, ADD3) mapping to 3 different chromosomes. A long series of parallel studies in the Milan hypertensive rat strain model of hypertension and humans indicated that an altered adducin function may cause hypertension through an enhanced constitutive tubular sodium reabsorption. Six human linkage studies showed positive results when a DNA marker mapping to 30 kb from the ADD1 locus or single-nucleotide polymorphisms (SNPs) of 1 of the 3 adducin genes were considered either alone or in combination with each other or angiotensin-converting enzyme (ACE) D allele or salt intake. When DNA markers mapping at much larger distance from the ADD1 locus were used, negative results were found by 4 studies. Positive results were also obtained in 18 of 20 association studies that, in addition to blood pressure, investigated variables reflecting body sodium or the renin-angiotensin system. Mixed results regarded case-control studies or studies in predominantly normotensive populations that did not consider the above-mentioned variables. Four of 5 studies showed a selective beneficial effect of diuretics in carriers of the mutated ADD1. Twelve of 16 studies found that ADD1 polymorphism alone or in combination with that of ACE positively associates with stroke or coronary heart disease or renal or vascular dysfunctions. In conclusion, when context is taken into account, the impact of adducin in hypertension and its related disorders is clear.
Revised on October 25, 2004
Adducin Polymorphism. Detection and Impact on Hypertension and Related Disorders
Giuseppe Bianchi*;
Key words: genetics • hypertension, essential • human • rats, spontaneously hypertensive • diuretics
This article has been cited by other articles:
 |
|
 |
|
  C. Mando, P. Antonazzo, S. Tabano, S. Zanutto, P. Pileri, E. Somigliana, F. Colleoni, A. Martinelli, A. Zolin, C. Benedetto, et al. Angiotensin-Converting Enzyme and Adducin-1 Polymorphisms in Women With Preeclampsia and Gestational Hypertension Reproductive Sciences, September 1, 2009; 16(9): 819 - 826. [Abstract] [PDF]
|
|
|
|
 |
|
 S. R. Thomas, P. Baconnier, J. Fontecave, J.-P. Francoise, F. Guillaud, P. Hannaert, A. Hernandez, V. Le Rolle, P. Maziere, F. Tahi, et al. SAPHIR: a physiome core model of body fluid homeostasis and blood pressure regulation Phil Trans R Soc A, September 13, 2008; 366(1878): 3175 - 3197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Zafarmand, Y. T. van der Schouw, D. E. Grobbee, P. W. de Leeuw, and M. L. Bots {alpha}-Adducin Gly460Trp Variant Increases the Risk of Stroke in Hypertensive Dutch Women Hypertension, June 1, 2008; 51(6): 1665 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cappuzzello, R. Melchionna, A. Mangoni, G. Tripodi, P. Ferrari, L. Torielli, D. Arcelli, M. Helmer-Citterich, G. Bianchi, M. C. Capogrossi, et al. Role of rat {alpha} adducin in angiogenesis: Null effect of the F316Y polymorphism Cardiovasc Res, August 1, 2007; 75(3): 608 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yazdanpanah, Y. S. Aulchenko, A. Hofman, J. A.M.J.L. Janssen, F. A. Sayed-Tabatabaei, R. H.N. van Schaik, O. H. Klungel, B. H.C.H. Stricker, H. A.P. Pols, J. C.M. Witteman, et al. Effects of the Renin-Angiotensin System Genes and Salt Sensitivity Genes on Blood Pressure and Atherosclerosis in the Total Population and Patients With Type 2 Diabetes Diabetes, July 1, 2007; 56(7): 1905 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pravenec and T. W. Kurtz Molecular Genetics of Experimental Hypertension and the Metabolic Syndrome: From Gene Pathways to New Therapies Hypertension, May 1, 2007; 49(5): 941 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. E. van Rijn, M. J. Bos, M. Yazdanpanah, A. Isaacs, A. Arias-Vasquez, P. J. Koudstaal, A. Hofman, J. C. Witteman, C. M. van Duijn, and M. M. B. Breteler {alpha}-Adducin Polymorphism, Atherosclerosis, and Cardiovascular and Cerebrovascular Risk Stroke, December 1, 2006; 37(12): 2930 - 2934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Guzman, B. Cormand, M. Ribases, D. Gonzalez-Nunez, A. Botey, and E. Poch Implication of Chromosome 18 in Hypertension by Sibling Pair and Association Analyses: Putative Involvement of the RKHD2 Gene Hypertension, November 1, 2006; 48(5): 883 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Manunta and G. Bianchi Pharmacogenomics and Pharmacogenetics of Hypertension: Update and Perspectives--The Adducin Paradigm J. Am. Soc. Nephrol., April 1, 2006; 17(4_suppl_2): S30 - S35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Blaustein, J. Zhang, L. Chen, and B. P. Hamilton How does salt retention raise blood pressure? Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R514 - R523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ferrari, M. Ferrandi, G. Valentini, and G. Bianchi Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R529 - R535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bianchi Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1536 - R1549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, L. Thijs, T. Kuznetsova, L. Zagato, H. Struijker-Boudier, G. Bianchi, and J. A. Staessen Cardiovascular Risk in Relation to {alpha}-Adducin Gly460Trp Polymorphism and Systolic Pressure: A Prospective Population Study Hypertension, September 1, 2005; 46(3): 527 - 532. [Abstract] [Full Text] [PDF]
|
|